Thermo Fisher Scientific Inc (TMO): Today's Featured Health Care Winner

Thermo Fisher Scientific ( TMO) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.7%. By the end of trading, Thermo Fisher Scientific rose $1.97 (2.4%) to $85.37 on average volume. Throughout the day, 3,206,947 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2,979,100 shares. The stock ranged in a price between $84.00-$85.76 after having opened the day at $84.09 as compared to the previous trading day's close of $83.40. Other companies within the Health Care sector that increased today were: Mela ( MELA), up 17.6%, ZIOPHARM Oncology ( ZIOP), up 16.2%, Cytokinetics ( CYTK), up 11.1% and Intercept Pharmaceuticals ( ICPT), up 9.8%.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $29.8 billion and is part of the health services industry. The company has a P/E ratio of 23.0, above the S&P 500 P/E ratio of 17.7. Shares are up 30.8% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Pingtan Marine Enterprise ( PME), down 65.1%, Mast Therapeutics ( MSTX), down 37.2%, Peregrine Pharmaceuticals ( PPHM), down 23.1% and PTC Therapeutics ( PTCT), down 15.1% , were all laggards within the health care sector with Vivus ( VVUS) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%